Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network.

Purpose: We aimed to validate the Multinational Association for Supportive Care in Cancer (MASCC) risk index, and compare it with the Talcott model and artificial neural network (ANN) in predicting the outcome of febrile neutropenia in a Chinese population.Methods: We prospectively enrolled adult ca...

Descripción completa

Detalles Bibliográficos
Publicado en:Supportive Care in Cancer Vol. 19; no. 10; pp. 1625 - 1636
Autores principales: Hui EP, Leung LK, Poon TC, Mo F, Chan VT, Ma AT, Poon A, Hui EK, Mak SS, Lai M, Lei KI, Ma BB, Mok TS, Yeo W, Zee BC, Chan AT, Hui, Edwin Pun, Leung, Linda K S, Poon, Terence C W, Mo, Frankie
Formato: research Journal Article
Publicado: Springer Nature Oct2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104579465&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104579465
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09414355
        O1J
      jtl: Supportive Care in Cancer
      issn: 09414355
      maglogo: N
    pubinfo:
      dt: Oct2011
      vid: 19
      iid: 10
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104579465
        65183078
        NLM20820815
        2011261197
        10.1007/s00520-010-0993-8
        NLM20820815
        104579465
      ppf: 1625
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network.
      aug:
        au:
          Hui EP
          Leung LK
          Poon TC
          Mo F
          Chan VT
          Ma AT
          Poon A
          Hui EK
          Mak SS
          Lai M
          Lei KI
          Ma BB
          Mok TS
          Yeo W
          Zee BC
          Chan AT
          Hui, Edwin Pun
          Leung, Linda K S
          Poon, Terence C W
          Mo, Frankie
        affil: Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
      sug:
        subj:
          Antineoplastic Agents Adverse Effects
          Models, Statistical
          Neural Networks (Computer)
          Neutropenia Chemically Induced
          Febrile Neutropenia
          Adult
          Antineoplastic Agents Therapeutic Use
          China
          Prospective Studies
          Female
          Fever Chemically Induced
          Human
          Male
          Middle Age
          Neoplasms Drug Therapy
          Neutropenia Ethnology
          Predictive Value of Tests
          ROC Curve
          Sensitivity and Specificity
          Treatment Outcomes
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Purpose: We aimed to validate the Multinational Association for Supportive Care in Cancer (MASCC) risk index, and compare it with the Talcott model and artificial neural network (ANN) in predicting the outcome of febrile neutropenia in a Chinese population.Methods: We prospectively enrolled adult cancer patients who developed febrile neutropenia after chemotherapy and risk classified them according to MASCC score and Talcott model. ANN models were constructed and temporally validated in prospectively collected cohorts.Results: From October 2005 to February 2008, 227 consecutive patients were enrolled. Serious medical complications occurred in 22% of patients and 4% died. The positive predictive value of low risk prediction was 86% (95% CI = 81-90%) for MASCC score ≥ 21, 84% (79-89%) for Talcott model, and 85% (78-93%) for the best ANN model. The sensitivity, specificity, negative predictive value, and misclassification rate were 81%, 60%, 52%, and 24%, respectively, for MASCC score ≥ 21; and 50%, 72%, 33%, and 44%, respectively, for Talcott model; and 84%, 60%, 58%, and 22%, respectively, for ANN model. The area under the receiver-operating characteristic curve was 0.808 (95% CI = 0.717-0.899) for MASCC, 0.573 (0.455-0.691) for Talcott, and 0.737 (0.633-0.841) for ANN model. In the low risk group identified by MASCC score ≥ 21 (70% of all patients), 12.5% developed complications and 1.9% died, compared with 43.3%, and 9.0%, respectively, in the high risk group (p < 0.0001).Conclusions: The MASCC risk index is prospectively validated in a Chinese population. It demonstrates a better overall performance than the Talcott model and is equivalent to ANN model.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N